Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | ||
| Other Working Capital | -30 | 26 |
| Other Operating Activity | -42 | -159 |
| Operating Cash Flow | $-72 | $-132 |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $N/A | $N/A |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 630 | 2,277 |
| Other Financing Activity | -35 | -233 |
| Financing Cash Flow | $595 | $2,044 |
| Beginning Cash Position | 1,866 | 0 |
| End Cash Position | 2,390 | 1,866 |
| Net Cash Flow | $524 | $1,866 |
| Free Cash Flow | ||
| Operating Cash Flow | -72 | -132 |
| Free Cash Flow | -72 | -132 |